| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Home Based Business > Network Marketing > Is It Really A Ground Floor Business Opportunity? |
|
Just Answers - Is It Really A Ground Floor Business Opportunity?
How many times have you heard from independent reps of network marketing companies that their opportunity is a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ground floor business opportunity? I’m sure more times than you ever wanted to. Certainly, everyone seeking ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in a network marketing business opportunity wants to be a part of a company that is relatively new. They all wa lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nt to get in on the ground floor because they believe that they have a greater chance of achieving success. N here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe etwork marketers know this and that’s exactly why so many of them promote this as a key selling point. So wha d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t really makes a company a ground floor business opportunity? Well, according to Dr. Charles King from the Un ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc iversity of Illinois companies usually go through four phases of growth. Those four phases are Formation, Con easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi centration, Momentum and Stability. Formation is when a company is just getting started and it does ab nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically out $1 million in monthly sales. Concentration happens when a company transitions to about $5 million and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ in monthly sales. Momentum occurs when a company expands into new territories and countries or it intr ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi oduces a new product and it experiences vertical (or straight upward) growth. Momentum can last for about 3 y ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ears and that is when most of the top money earners are made. Stability happens when a company has gon dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e through momentum. However, companies can extend their momentum or even go into another stage of momentum wi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin th the offering of new products or expanding into new markets, as previously stated. So, with that being said, tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the next time someone tells you that their business is a ground floor opportunity, you can now asks specific t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel questions or do a little research to find out for sure. Once a network marketing has gone through momentum, t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust he chance to experience life-style changing income is not as likely as it may have been in the beginning. Nev y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ertheless, you should not take that to mean that the opportunity is not still a good one. It simply means tha . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t most likely you will most likely not earn as much as those who joined and stayed the course from the beginni elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ng. The bottom line is that you still can earn a good income. It just may take you a little longer to do it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Casual Selling Through Sensitive Networking Three Way Mirror Dresses up Retail Dressing Room Space Money Can Still be Made on the Internet
|